Organoprotecive effects of angiotensin II receptor blockers in patients with type 2 diabetes mellitus

High prevalence of arterial hypertension and related cardiovascular complications dictates the necessity of preparations possessed of markedorganoprotective activity and good tolerability. The currently available data suggest advantages of iACE and ARB as preparations for the treatmentof cardiovascu...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ivona Yanovna Yarek-Martynova, Minara Shamkhalovna Shamkhalova
Formato:	article
Lenguaje:	EN RU
Publicado:	Endocrinology Research Centre 2010
Materias:	telmisartan angiotensin ii ontarget transcend Nutritional diseases. Deficiency diseases RC620-627
Acceso en línea:	https://doaj.org/article/fd87b527978f40e1b8fff9607c0aa113
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:fd87b527978f40e1b8fff9607c0aa113
record_format	dspace
spelling	oai:doaj.org-article:fd87b527978f40e1b8fff9607c0aa1132021-11-14T09:00:15ZOrganoprotecive effects of angiotensin II receptor blockers in patients with type 2 diabetes mellitus2072-03512072-037810.14341/2072-0351-5675https://doaj.org/article/fd87b527978f40e1b8fff9607c0aa1132010-06-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/5675https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378High prevalence of arterial hypertension and related cardiovascular complications dictates the necessity of preparations possessed of markedorganoprotective activity and good tolerability. The currently available data suggest advantages of iACE and ARB as preparations for the treatmentof cardiovascular diseases such as ability of iACE to improve clinical picture and outcome of therapy of cardiac insufficiency, left ventricle dysfunction,and myocardial infarction. Large-scale prospective studies demonstrated effectiveness of these agents in the treatment of CHD, stroke, diabetes, renalpathology and revealed their additional advantages attributable to inhibition of angiotensin II secretion other than those related to reduction of AP.These studies gave evidence of a more pronounced decrease in the frequency of cardiovascular events under effect of ARB in high-risk patients. However,protective action of ARB on the cardiovascular system compared with that of iACE and combination of ARB+iACE awaits an in-depth study.Ivona Yanovna Yarek-MartynovaMinara Shamkhalovna ShamkhalovaEndocrinology Research Centrearticletelmisartanangiotensin iiontargettranscendNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 13, Iss 2, Pp 58-61 (2010)
institution	DOAJ
collection	DOAJ
language	EN RU
topic	telmisartan angiotensin ii ontarget transcend Nutritional diseases. Deficiency diseases RC620-627
spellingShingle	telmisartan angiotensin ii ontarget transcend Nutritional diseases. Deficiency diseases RC620-627 Ivona Yanovna Yarek-Martynova Minara Shamkhalovna Shamkhalova Organoprotecive effects of angiotensin II receptor blockers in patients with type 2 diabetes mellitus
description	High prevalence of arterial hypertension and related cardiovascular complications dictates the necessity of preparations possessed of markedorganoprotective activity and good tolerability. The currently available data suggest advantages of iACE and ARB as preparations for the treatmentof cardiovascular diseases such as ability of iACE to improve clinical picture and outcome of therapy of cardiac insufficiency, left ventricle dysfunction,and myocardial infarction. Large-scale prospective studies demonstrated effectiveness of these agents in the treatment of CHD, stroke, diabetes, renalpathology and revealed their additional advantages attributable to inhibition of angiotensin II secretion other than those related to reduction of AP.These studies gave evidence of a more pronounced decrease in the frequency of cardiovascular events under effect of ARB in high-risk patients. However,protective action of ARB on the cardiovascular system compared with that of iACE and combination of ARB+iACE awaits an in-depth study.
format	article
author	Ivona Yanovna Yarek-Martynova Minara Shamkhalovna Shamkhalova
author_facet	Ivona Yanovna Yarek-Martynova Minara Shamkhalovna Shamkhalova
author_sort	Ivona Yanovna Yarek-Martynova
title	Organoprotecive effects of angiotensin II receptor blockers in patients with type 2 diabetes mellitus
title_short	Organoprotecive effects of angiotensin II receptor blockers in patients with type 2 diabetes mellitus
title_full	Organoprotecive effects of angiotensin II receptor blockers in patients with type 2 diabetes mellitus
title_fullStr	Organoprotecive effects of angiotensin II receptor blockers in patients with type 2 diabetes mellitus
title_full_unstemmed	Organoprotecive effects of angiotensin II receptor blockers in patients with type 2 diabetes mellitus
title_sort	organoprotecive effects of angiotensin ii receptor blockers in patients with type 2 diabetes mellitus
publisher	Endocrinology Research Centre
publishDate	2010
url	https://doaj.org/article/fd87b527978f40e1b8fff9607c0aa113
work_keys_str_mv	AT ivonayanovnayarekmartynova organoproteciveeffectsofangiotensiniireceptorblockersinpatientswithtype2diabetesmellitus AT minarashamkhalovnashamkhalova organoproteciveeffectsofangiotensiniireceptorblockersinpatientswithtype2diabetesmellitus
_version_	1718429628838707200

Organoprotecive effects of angiotensin II receptor blockers in patients with type 2 diabetes mellitus

Ejemplares similares